1.Aortic Flow Propagation Velocity in Patients with Familial Mediterranean Fever: an Observational Study.
Kayihan KARAMAN ; Arif ARISOY ; Aysegul ALTUNKAS ; Ertugrul ERKEN ; Ahmet DEMIRTAS ; Mustafa OZTURK ; Metin KARAYAKALI ; Safak SAHIN ; Atac CELIK
Korean Circulation Journal 2017;47(4):483-489
BACKGROUND AND OBJECTIVES: Systemic inflammation has an important role in the initiation of atherosclerosis, which is associated with arterial stiffness (AS). Aortic flow propagation velocity (APV) is a new echocardiographic parameter of aortic stiffness. The relationship between systemic inflammation and AS has not yet been described in patients with familial Mediterranean fever (FMF). We aimed to investigate the early markers of AS in patients with FMF by measuring APV and carotid intima-media thickness (CIMT). SUBJECTS AND METHODS: Sixty-one FMF patients (43 women; mean age 27.3±6.7 years) in an attack-free period and 57 healthy individuals (36 women; mean age 28.8±7.1 years) were included in this study. The individuals with atherosclerotic risk factors were excluded from the study. The flow propagation velocity of the descending aorta and CIMT were measured to assess AS. RESULTS: APV was significantly lower (60.2±16.5 vs. 89.5±11.6 cm/sec, p<0.001) and CIMT was significantly higher (0.49±0.09 vs. 0.40±0.10 mm, p<0.001) in the FMF group compared to the control group. There were significant correlations between APV and mean CIMT (r=-0.424, p<0.001), erythrocyte sedimentation rate (ESR) (r=-0.198, p=0.032), and left ventricle ejection fraction (r=0.201, p=0.029). APV and the ESR were independent predictors of FMF in logistic regression analysis (OR=-0.900, 95% CI=0.865-0.936, p<0.001 and OR=-1.078, 95% CI=1.024-1.135, p=0.004, respectively). Mean CIMT and LVEF were independent factors associated with APV in linear regression analysis (β=-0.423, p<0.001 and β=0.199, p=0.017, respectively). CONCLUSION: We demonstrated that APV was lower in FMF patients and is related to CIMT. According to our results, APV may be an independent predictor of FMF.
Aorta, Thoracic
;
Atherosclerosis
;
Blood Sedimentation
;
Carotid Intima-Media Thickness
;
Echocardiography
;
Familial Mediterranean Fever*
;
Female
;
Heart Ventricles
;
Humans
;
Inflammation
;
Linear Models
;
Logistic Models
;
Observational Study*
;
Risk Factors
;
Vascular Stiffness
2.A New Method for Patent Foramen Ovale Closure: Delivering Sheath Over Coronary Sinus Catheter into Left Atrium.
Tayyar GOKDENIZ ; Ahmet Cagri AYKAN ; Sukru CELIK ; Faruk BOYACI
Korean Circulation Journal 2013;43(2):139-141
Patent foramen ovale (PFO) is a frequent condition. It usually does not pose any threat to life, but in certain circumstances, it can open and serve as a conduit for thrombi causing paradoxical embolism. Herein, we report a case of PFO in a patient with ischemic cerebrovascular accident, due to paradoxical embolism, which could not be passed via general practice; hence it was crossed with coronary sinus catheter, through which the delivery sheath was placed into the left atrium, and it was successfully closed.
Catheters
;
Coronary Sinus
;
Embolism, Paradoxical
;
Foramen Ovale, Patent
;
Heart Atria
;
Humans
;
Septal Occluder Device
;
Stroke
3.A New Method for Patent Foramen Ovale Closure: Delivering Sheath Over Coronary Sinus Catheter into Left Atrium.
Tayyar GOKDENIZ ; Ahmet Cagri AYKAN ; Sukru CELIK ; Faruk BOYACI
Korean Circulation Journal 2013;43(2):139-141
Patent foramen ovale (PFO) is a frequent condition. It usually does not pose any threat to life, but in certain circumstances, it can open and serve as a conduit for thrombi causing paradoxical embolism. Herein, we report a case of PFO in a patient with ischemic cerebrovascular accident, due to paradoxical embolism, which could not be passed via general practice; hence it was crossed with coronary sinus catheter, through which the delivery sheath was placed into the left atrium, and it was successfully closed.
Catheters
;
Coronary Sinus
;
Embolism, Paradoxical
;
Foramen Ovale, Patent
;
Heart Atria
;
Humans
;
Septal Occluder Device
;
Stroke
4.Acute pulmonary thromboemboli due to a giant mobile thrombus.
Ataman KÖSE ; Mehmet Kerem KARACA ; Ahmet CELIK ; Serdar BIRICIK ; Murat OZEREN
Clinical and Experimental Emergency Medicine 2017;4(2):117-118
No abstract available.
Thrombosis*
5.Impact of lymph node ratio on survival in stage IIIC endometrioid endometrial cancer: a Turkish Gynecologic Oncology Group study.
Ali AYHAN ; Nazlı TOPFEDAISI OZKAN ; Murat ÖZ ; Günsu KIMYON COMERT ; Zeliha FIRAT CUYLAN ; Gonca ÇOBAN ; Osman TURKMEN ; Baki ERDEM ; Hanifi ŞAHIN ; Ozgür AKBAYIR ; Murat DEDE ; Ahmet Taner TURAN ; Husnu CELIK ; Tayfun GÜNGÖR ; Ali HABERAL ; Macit ARVAS ; Mehmet Mutlu MEYDANLI
Journal of Gynecologic Oncology 2018;29(4):e48-
OBJECTIVE: The purpose of this study was to investigate the prognostic value of lymph node ratio (LNR) in women with stage IIIC endometrioid endometrial cancer (EC). METHODS: A multicenter, retrospective department database review was performed to identify patients with stage IIIC pure endometrioid EC at 6 gynecologic oncology centers in Turkey. A total of 207 women were included. LNR, defined as the percentage of positive lymph nodes (LNs) to total nodes recovered, was stratified into 2 groups: LNR1 (≤0.15), and LNR2 (>0.15). Kaplan-Meier method was used to generate survival data. Factors predictive of outcome were analyzed using Cox proportional hazards models. RESULTS: One hundred and one (48.8%) were classified as stage IIIC1 and 106 (51.2%) as stage IIIC2. The median age at diagnosis was 58 (range, 30–82) and the median duration of follow-up was 40 months (range, 1–228 months). There were 167 (80.7%) women with LNR ≤0.15, and 40 (19.3%) women with LNR >0.15. The 5-year progression-free survival (PFS) rates for LNR ≤0.15 and LNR >0.15 were 76.1%, and 58.5%, respectively (p=0.045). An increased LNR was associated with a decrease in 5-year overall survival (OS) from 87.0% for LNR ≤0.15 to 62.3% for LNR >0.15 (p=0.005). LNR >0.15 was found to be an independent prognostic factor for both PFS (hazard ratio [HR]=2.05; 95% confidence interval [CI]=1.07–3.93; p=0.03) and OS (HR=3.35; 95% CI=1.57–7.19; p=0.002). CONCLUSION: LNR seems to be an independent prognostic factor for decreased PFS and OS in stage IIIC pure endometrioid EC.
Carcinoma, Endometrioid
;
Diagnosis
;
Disease-Free Survival
;
Endometrial Neoplasms*
;
Female
;
Follow-Up Studies
;
Humans
;
Lymph Node Excision
;
Lymph Nodes*
;
Methods
;
Proportional Hazards Models
;
Retrospective Studies
;
Survival Rate
;
Turkey